Destiny 2 has a big 2026 ahead, from new expansions, to Major Updates and much more. Check out our full preview of the year ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

Enhertu showed improved iDFS over Kadcyla in early-stage HER2-positive breast cancer with residual disease post-neoadjuvant ...

Final Boss #2 drops this Christmas Eve as Tommy Brazen discovers his grandfather's stories about godlike abilities weren't just bedtime tales.

NetEase announces Destiny Rising holiday event, and responds to feedback about scarce free rewards, promising improvements, so monetization isn't a wall to enjoyment.

The FDA approved fam-trastuzumab derextecan-nki (Enhertu; Daiichi Sankyo, Inc), a HER2-directed antibody-drug conjugate (ADC), in combination with pertuzumab as a first-line treatment for patients ...

The FDA approved T-DXd plus pertuzumab for HER2-positive metastatic breast cancer, based on DESTINY-Breast09 trial results. The combination therapy reduced disease progression or death risk by 44% ...

Bungie and Lucasfilm's intriguing new collaboration nails the 'Star Wars' vibe, but if you're looking to hop in from one galaxy far, far away to another closer to home... it's still 'Destiny 2', warts ...

At least to a certain extent, Bungie’s idea to do a Star Wars expansion, Renegades, may work on some players. I’ve heard some amount of players saying they’re either thinking of returning to the game, ...

The Praxic Blade is Destiny 2’s take on the iconic Lightsaber. Players will have a chance to customize the Blade. You can change the Blade’s color through crystals. There are other customization ...

'Renegades,' the 'Star Wars'-inspired upcoming expansion for Bungie's sci-fi shooter, will bring you plenty of firepower from a galaxy far, far away... and, of course, a certain laser sword. Reading ...